ArticleCurrent cancer drug targets2025
Complement Factor H Promotes the Growth of Lung Adenocarcinoma Cells through the JAK2/STAT3 Signaling Pathway.
Kaili Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it